Does Cervical Pessary Prevent Spontaneous Preterm Birth in Twin Pregnancies With Short Cervical Length?
- Conditions
- Preterm Birth
- Interventions
- Device: Cervical pessary
- Registration Number
- NCT02708264
- Lead Sponsor
- Federico II University
- Brief Summary
Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. Multiple gestations are at increased risk of SPTB. A short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB, in both singletons and twins.
The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of the cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on use of the cervical pessary in pregnancy or guidelines for management have been assessed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 242
- 18-50 years of age
- Twin pregnancy (limits the participants to female gender)
- Short cervical length (less than or equal to 30 mm) on second trimester ultrasound at 18-23 6/7 weeks gestation
- Singleton or higher order than twins multiple gestation
- Monoamniotic twins
- Twin twin transfusion syndrome
- Ruptured membranes
- Lethal fetal structural anomaly
- Fetal chromosomal abnormality
- Cerclage in place (or planned placement)
- Vaginal bleeding
- Suspicion of chorioamnionitis
- Ballooning of membranes outside the cervix into the vagina
- Painful regular uterine contractions
- Labor
- Placenta previa
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cervical Pessary Cervical pessary The cervical pessary is a silicone device that has been used to prevent SPTB Pessary will be placed between 18 and 23 6/7 weeks gestation, and will be removed during the 36th week of pregnancy (or earlier if indicated)
- Primary Outcome Measures
Name Time Method Spontaneous Preterm delivery <34 weeks Less than 34 weeks gestation
- Secondary Outcome Measures
Name Time Method Spontaneous rupture of membranes Less than 34 weeks gestation Rupture of membranes \<34 weeks
Type of delivery (if cesarean or operativa vaginal or spontaneous vaginal delivery) Time of delivery cesarean delivery, operative vaginal delivery, spontaneous vaginal delivery
Composite perinatal outcome Between birth and 28 days of age Includes necrotizing enterocolitis, intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia (BPD), retinopathy, blood-culture proven sepsis and neonatal death
Birth weight Time of delivery Gestational age Time of delivery Spontaneous preterm birth rates <37, <28 and <24 weeks Less than 24, 28, 34 and 37 weeks gestation Neonatal death Between birth and 28 days of age Maternal side effects Maternal side effects
Trial Locations
- Locations (1)
Gabriele Saccone
🇮🇹Napoli, Italy